Ntla stock earnings

27 Feb 2020 NTLA earnings call for the period ending December 31, 2019. and $4.2 million in proceeds from the employee-based stock plans.

Stock analysis for Intellia Therapeutics Inc (NTLA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. NTLA Stock | INTELLIA THERAPEUTICS Stock Price Today ... NTLA: Get the latest Intellia Therapeutics stock price and detailed information including NTLA news, historical charts and realtime prices. NTLA Stock Price & Charts | Intellia Therapeutics In depth view into NTLA (Intellia Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. Intellia Therapeutics (NasdaqGM:NTLA) - Share price, News ...

NTLA - Intellia Therapeutics, Inc. Summary, Stock Quote ...

Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. It utilizes a biological tool known as the Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. Intellia Therapeutics Stock Forecast: down to 8.628 USD ... Historical index on US Stock Market : A "Should I invest in Intellia Therapeutics stock?" "Should I trade "NTLA" stock today?" According to our live Forecast System, Intellia Therapeutics, Inc stock is a bad long-term (1-year) investment*. "NTLA" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Intellia Therapeutics Inc : NTLA Stock Price Quote at Ally ... Free current stock price quotes and data for Intellia Therapeutics Inc (NTLA). Research news, charts, stock market performance and earnings. NTLA Stock Quote of Intellia Thera CS Check out our NTLA stock analysis, current NTLA quote, charts, and historical prices for Intellia Thera CS stock. NTLA earnings call for the period ending December 31, 2019.

Apr 03, 2020 · Explore commentary on Intellia Therapeutics Inc. and hear what the experts at TheStreet are saying about NTLA. I'm Joining Insiders In Buying Arcadia Biosciences Stock. Earnings and

Find the latest and the upcoming Intellia Therapeutics earnings report Mar 31, 2020 as well as EPS Forecast and NTLA top analyst price The TipRanks Smart Score analyzes stocks based on 8 factors extracted from our unique datasets. 27 Feb 2020 This quarterly report represents an earnings surprise of -5.56%. A quarter ago, it was expected that this company would post a loss of $0.61 per  (NTLA) delivered earnings and revenue surprises of -5.56% and 14.56%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what  27 Feb 2020 NTLA earnings call for the period ending December 31, 2019. and $4.2 million in proceeds from the employee-based stock plans.

NTLA - Intellia Thera CS Stock Earnings Estimates ...

Apr 03, 2020 · Stock quote and company snapshot for INTELLIA THERAPEUTICS INC (NTLA), including profile, stock chart, recent news and events, analyst opinions, and research reports. Intellia Therapeutics, Inc. (NTLA) Stock Forum ... Find the latest Intellia Therapeutics, Inc. (NTLA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Intellia Therapeutics, Inc. (NTLA) Earnings Report ... Intellia Therapeutics, Inc. (NTLA) latest earnings report: revenue, EPS, surprise, history, news and analysis. Earnings Whisper Number for NTLA: Intellia Thera CS Oct 31, 2019 · Intellia Thera CS (NTLA) reports earnings on 5/28/2020. Shares are down 7.2% since reporting last quarter. The Earnings Whisper Score gives the …

Intellia Therapeutics Stock Quote: NTLA Stock News, Quotes ...

27 Feb 2020 On track to submit an IND application for NTLA-2001 for the treatment of and $4.2 million in proceeds from employee-based stock plans. Conference Call to Discuss Fourth Quarter and Full Year 2019 Earnings. 4 Mar 2020 EPS growth is a percentage change in standardized earnings per share After an ongoing check, Intellia Therapeutics Inc. (NTLA) stock is  NTLA. Delayed Nasdaq - 03/20 04:00:00 pm. 12.07USD. -3.29% Call to Discuss Fourth Quarter and Full-Year 2019 Earnings and Company Update. GL. 16 Mar 2020 The stock added 4.18% to value at $11.46 on Friday trading session. and excitability of Intellia Therapeutics (NTLA) stock, it purposes common trait for The price-to-earnings ratio or P/E is one of the most widely-used stock  View detailed financial information, real-time news, videos, quotes and analysis on Intellia Therapeutics Inc. (NASDAQ:NTLA). Explore commentary on Intellia  for Intellia Therapeutics Inc. (NTLA). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.

View detailed financial information, real-time news, videos, quotes and analysis on Intellia Therapeutics Inc. (NASDAQ:NTLA). Explore commentary on Intellia  for Intellia Therapeutics Inc. (NTLA). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.